Capstone Investment Advisors
CLVS

Capstone Investment Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Capstone Investment Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,803
Closed -$21.2K – 1383
2020
Q1 		$18K Buy
+2,803
New +$22.5K ﹤0.01% 1099
2019
Q4 		– Sell
-34,668
Closed -$252K – 1477
2019
Q3 		$136K Buy
+34,668
New +$280K ﹤0.01% 1266

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Capstone Investment Advisors's CLVS Position: Q2 2020 in Review

Capstone Investment Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q2 2020, closing a stake of 2,803 shares — an estimated $21.2K sold.

Capstone Investment Advisors first reported a position in CLVS in Q3 2019 and held it in 2 quarters. The position peaked at $136K in Q3 2019. 158 funds tracked by Wall St. Rank hold CLVS as of Q2 2020.

  • Capstone Investment Advisors reported no remaining Clovis Oncology, Inc. position as of Q2 2020 after selling out during the quarter.
  • Capstone Investment Advisors sold 2,803 Clovis Oncology, Inc. shares in Q2 2020, an estimated $21.2K.
  • Capstone Investment Advisors first reported a position in Clovis Oncology, Inc. in Q3 2019 and held it in 2 quarters.
  • Capstone Investment Advisors's Clovis Oncology, Inc. position peaked at $136K in Q3 2019.
  • 158 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2020.

Based on Capstone Investment Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.